Cannabis CBD ECJ CBD ruling and Biden election victory could spark investment surge into global cannabis sector

Both events could herald a regulatory sea change in two huge markets for the industry

7 hours, 59 minutes ago

Will AstraZeneca rebound after slipping on Monday’s COVID-19 vaccine news?

The pharma giant could reap the long-term benefits from higher reputation – ‘no vax’ movements...

9 hours, 12 minutes ago

What are the differences between the COVID-19 vaccines developed by...

The FTSE 100 firm dipped after posting lower efficacy than its competitors, but the upside lies...

1 day, 8 hours ago
Big caps

Moderna’s COVID-19 vaccine candidate can be stored at warmer temperatures...

The ultra-cold temperatures needed by Pfizer's jab may be a significant hurdle for its distribution

1 week, 1 day ago

ImmuPharma set to meet FDA in December to discuss phase III lupus clinical trial

Dr Tim Franklin, Chief Operating Officer of ImmuPharma PLC (LON:IMM) joins Proactive London's Katie Pilbeam to discuss ImmuPharma's announcement that The US Food & Drug Administration (“FDA”) has confirmed 4th December 2020 will be the date for the Type ‘A’ Meeting Request, with Avion...

10 hours, 36 minutes ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.